Deferasirox
- Product NDC
- 0480-7013
- 11-digit product format
- 004807013
- Labeler code
- 0480
- Product ID
- 0480-7013_41368299-3cb6-4cee-885e-5c1cc8e4fee6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Deferasirox
- Dosage form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals, Inc.
- Application
- ANDA207124
- Marketing category
- ANDA
- Marketing start
- 2024-11-01
- Substance
- DEFERASIROX
- Active strength
- 500 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| V8G4MOF2V9 | DEFERASIROX | 201530-41-8 | DEFERASIROX |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 0480-7013-56 | 00480701356 | 30 TABLET, FOR SUSPENSION in 1 BOTTLE (0480-7013-56) | 2024-11-01 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Deferasirox | Teva Pharmaceuticals, Inc. | 2024-07-01 | HUMAN PRESCRIPTION DRUG LABEL | 7 |